P PRIMESTOCKFINDER.COM

ACP Shares Audalia Resources Limited

ASX · ASX
$0.02 +0.00% Prices as of close 2026-10-27

Last in our picks 2026-10-19 — not in the current list; analysis below is from that screen

Hearing-health technology targets a large underserved market with potential platform expansion.

Future value: $0.03 (+36.36%) · 6-12 months

  • ▸Product commercialization and market-expansion potential.
  • ▾Below 50-day MA (-4.68%)
  • ▸Volume 2.13× average — accumulation
  • ▸~36% upside to price target

Trend: ACP is trading above the 50-day average (+10.00%), RSI 16 — oversold territory, with a 3-month return of -12.00%.

Valuation & quality: Audalia Resources Limited trades on price-to-book 5.50; fundamentals show net margin 0.0%, return on equity -38.0%, revenue growth -91.8% year on year.

Our screen: BUY (score 2) — Hearing-health technology targets a large underserved market with potential platform expansion.

Computed from end-of-day data; not personal advice.

0.03 0.02 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-26 (AUD). Range 0.02 – 0.03.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+50.00%+0.00%-33.30%+50.00%+0.00%-33.30%+0.00%+0.00%
Market cap
$19.3M
EPS (ttm)
$0.00
Price / book
5.50
Beta
-0.03
Net margin
0.0%
ROE
-38.0%
Revenue growth
-91.8%
Revenue (ttm)
$3,127
Free cash flow
$2.2M
Debt / equity
160%
52-wk range
$0.02 – $0.03
Volume
10,004
Avg volume (3m)
2,652
RSI (14)
15.8
vs 50-day MA
+10.00%
1-mo return
+0.00%
3-mo return
-12.00%
Volume z-score
-0.37

Audalia Resources Limited engages in the exploration and evaluation of mineral properties in Australia. It primarily explores vanadium, titanium, and iron deposits.

Sector: Basic Materials · Industry: Other Industrial Metals & Mining · Australia · Website

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.